- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Measuring Performance of Patient-Centered Outcomes Research
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding and there are 3 ways to measure performance in patient-centered outcomes research.
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding to determine whether levels should be adjusted in autumn 2019. And now researchers are analyzing work in patient-centered outcomes research to ascertain how well the work is being done and what might be done better, according to a new commentary from RAND.
The Patient-Centered Outcomes Research Institute, established in 2010, has funded hundreds of studies and Thomas W. Concannon, senior policy researcher at RAND, highlights 3 ways to measure performance in patient-centered outcomes research:
- Ongoing and public inventory to explain how trust fund dollars earmarked for patient-centered outcomes research have been spent
- Procedural assessments to examine whether investigators are getting the principles of patient centeredness right
- Evaluation of whether patient-centered outcomes research is making a difference to healthcare quality and outcomes
Read the full commentary at RAND.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
